# Triller Group Inc.: financial statements, quarterly

ILLR · OTC · CIK 1769624 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/illr.md) · [Financials](/companies/illr/financials.md) · [Filings](/companies/illr/filings.md) · [Insiders](/companies/illr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/illr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [13.2](/filings/0001213900-24-098416.md) | [12.5 d](/filings/0001213900-26-007545.md) | [7.7](/filings/0001213900-26-016753.md) | [4.9](/filings/0001213900-26-016763.md) | [5.4](/filings/0001213900-26-043228.md) | [9.5 d](/filings/0001213900-26-043341.md) | [4.8](/filings/0001213900-26-055478.md) | [5.5](/filings/0001213900-26-089062.md) | [5.7](/filings/0001213900-26-043228.md) | [5.7 d](/filings/0001213900-26-043341.md) | [5.0](/filings/0001213900-26-055478.md) | [5.2](/filings/0001213900-26-089062.md) |
| Research and development | $m | [0.7](/filings/0001213900-24-098416.md) | [1.9 d](/filings/0001213900-26-007545.md) | [0.5](/filings/0001213900-26-016753.md) | [0.5](/filings/0001213900-26-016763.md) | [0.4](/filings/0001213900-26-043228.md) | [1.8 d](/filings/0001213900-26-043341.md) | [1.7](/filings/0001213900-26-055478.md) | [1.4](/filings/0001213900-26-089062.md) | [1.1](/filings/0001213900-26-043228.md) | [(0.0) d](/filings/0001213900-26-043341.md) | [0.5](/filings/0001213900-26-055478.md) | [0.3](/filings/0001213900-26-089062.md) |
| Operating income | $m | [(11.3)](/filings/0001213900-24-098416.md) | [(6.7) d](/filings/0001213900-26-007545.md) | [(7.7)](/filings/0001213900-26-016753.md) | [(7.4)](/filings/0001213900-26-016763.md) | [(9.0)](/filings/0001213900-26-043228.md) | [(89.1) d](/filings/0001213900-26-043341.md) | [(44.2)](/filings/0001213900-26-055478.md) | [(28.8)](/filings/0001213900-26-089062.md) | [(23.1)](/filings/0001213900-26-043228.md) | [(42.3) d](/filings/0001213900-26-043341.md) | [(27.7)](/filings/0001213900-26-055478.md) | [(22.6)](/filings/0001213900-26-089062.md) |
| Interest expense | $m | [0.4](/filings/0001213900-24-027214.md) | [(0.0) d](/filings/0001213900-24-027225.md) | [0.2](/filings/0001213900-24-043747.md) | [0.4](/filings/0001213900-26-016763.md) | [1.1](/filings/0001213900-26-043228.md) | [5.2 d](/filings/0001213900-26-043341.md) | [4.8](/filings/0001213900-26-016753.md) | [5.2](/filings/0001213900-26-016763.md) | [3.7](/filings/0001213900-26-043228.md) | [0.1 d](/filings/0001213900-26-043341.md) | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001213900-24-098416.md) | [0.2 d](/filings/0001213900-26-007545.md) | [0.0](/filings/0001213900-26-016753.md) | [0.0](/filings/0001213900-26-016763.md) | [0.0](/filings/0001213900-26-043228.md) | not reported | [0.0](/filings/0001213900-26-055478.md) | [0.0](/filings/0001213900-26-089062.md) | [0.0](/filings/0001213900-26-043228.md) | [0.0 d](/filings/0001213900-26-043341.md) | [0.1](/filings/0001213900-26-055478.md) | [0.1](/filings/0001213900-26-089062.md) |
| Net income | $m | [(12.9)](/filings/0001213900-24-098416.md) | [(13.6) d](/filings/0001213900-26-007545.md) | [(8.1)](/filings/0001213900-26-016753.md) | [(11.4)](/filings/0001213900-26-016763.md) | [(9.4)](/filings/0001213900-26-043228.md) | [(1,109) d](/filings/0001213900-26-043341.md) | [(53.1)](/filings/0001213900-26-055478.md) | [(32.2)](/filings/0001213900-26-089062.md) | [(27.4)](/filings/0001213900-26-043228.md) | [(61.9) d](/filings/0001213900-26-043341.md) | [(32.2)](/filings/0001213900-26-055478.md) | [(28.4)](/filings/0001213900-26-089062.md) |
| Diluted EPS | $ per share | [(0.40)](/filings/0001213900-24-098416.md) | not reported | [(0.24)](/filings/0001213900-26-016753.md) | [(0.30)](/filings/0001213900-26-016763.md) | [(0.60)](/filings/0001213900-26-043228.md) | not reported | [(0.32)](/filings/0001213900-26-055478.md) | [(1.79)](/filings/0001213900-26-089062.md) | [(0.18)](/filings/0001213900-26-043228.md) | not reported | [(0.16)](/filings/0001213900-26-055478.md) | [(1.42)](/filings/0001213900-26-089062.md) |
| Basic EPS | $ per share | [(0.40)](/filings/0001213900-24-098416.md) | not reported | [(0.24)](/filings/0001213900-26-016753.md) | [(0.30)](/filings/0001213900-26-016763.md) | [(0.60)](/filings/0001213900-26-043228.md) | not reported | [(0.32)](/filings/0001213900-26-055478.md) | [(1.79)](/filings/0001213900-26-089062.md) | [(0.18)](/filings/0001213900-26-043228.md) | not reported | [(0.16)](/filings/0001213900-26-055478.md) | [(1.42)](/filings/0001213900-26-089062.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-04-12) | Q2 FY2024 (2024-06-30) | period not labelled (2024-07-31) | Q3 FY2024 (2024-09-30) | period not labelled (2024-10-31) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.2](/filings/0001213900-26-089062.md) | [1.8](/filings/0001213900-24-068997.md) | [0.1](/filings/0001213900-26-016753.md) | [5.1](/filings/0001213900-24-098416.md) | [1.6](/filings/0001213900-26-007545.md) | [3.1](/filings/0001213900-26-043341.md) | [2.1](/filings/0001213900-26-016753.md) | [2.1](/filings/0001213900-26-016763.md) | [2.9](/filings/0001213900-26-043228.md) | [2.3](/filings/0001213900-26-089062.md) | [2.2](/filings/0001213900-26-055478.md) | [2.1](/filings/0001213900-26-089062.md) |
| Current assets | $m | not reported | [51.8](/filings/0001213900-24-068997.md) | not reported | [52.1](/filings/0001213900-24-098416.md) | not reported | [24.1](/filings/0001213900-26-043341.md) | [18.3](/filings/0001213900-26-016753.md) | [17.1](/filings/0001213900-26-016763.md) | [16.8](/filings/0001213900-26-043228.md) | [15.2](/filings/0001213900-26-089062.md) | [14.3](/filings/0001213900-26-055478.md) | [14.1](/filings/0001213900-26-089062.md) |
| Total assets | $m | not reported | [89.3](/filings/0001213900-24-068997.md) | not reported | [96.4](/filings/0001213900-24-098416.md) | not reported | [50.6](/filings/0001213900-26-043341.md) | [45.4](/filings/0001213900-26-016753.md) | [45.4](/filings/0001213900-26-016763.md) | [44.1](/filings/0001213900-26-043228.md) | [35.5](/filings/0001213900-26-089062.md) | [34.3](/filings/0001213900-26-055478.md) | [33.9](/filings/0001213900-26-089062.md) |
| Current liabilities | $m | not reported | [87.3](/filings/0001213900-24-068997.md) | not reported | [92.6](/filings/0001213900-24-098416.md) | not reported | [296](/filings/0001213900-26-043341.md) | [313](/filings/0001213900-26-016753.md) | [328](/filings/0001213900-26-016763.md) | [340](/filings/0001213900-26-043228.md) | [361](/filings/0001213900-26-089062.md) | [381](/filings/0001213900-26-055478.md) | [405](/filings/0001213900-26-089062.md) |
| Total liabilities | $m | not reported | [97.4](/filings/0001213900-24-068997.md) | not reported | [102](/filings/0001213900-24-098416.md) | not reported | [297](/filings/0001213900-26-043341.md) | [313](/filings/0001213900-26-016753.md) | [328](/filings/0001213900-26-016763.md) | [340](/filings/0001213900-26-043228.md) | [364](/filings/0001213900-26-089062.md) | [383](/filings/0001213900-26-055478.md) | [407](/filings/0001213900-26-089062.md) |
| Short-term borrowings | $m | not reported | [1.8](/filings/0001213900-24-068997.md) | not reported | [1.1](/filings/0001213900-24-098416.md) | not reported | [41.9](/filings/0001213900-26-043341.md) | [11.6](/filings/0001213900-26-016753.md) | [11.7](/filings/0001213900-26-016763.md) | [11.6](/filings/0001213900-26-043228.md) | [60.4](/filings/0001213900-26-089062.md) | [62.6](/filings/0001213900-26-055478.md) | [64.2](/filings/0001213900-26-089062.md) |
| Shareholders' equity | $m | not reported | [(8.1)](/filings/0001213900-26-016763.md) | not reported | [(5.9)](/filings/0001213900-26-043228.md) | not reported | [(246)](/filings/0001213900-26-089062.md) | [(267)](/filings/0001213900-26-055478.md) | [(282)](/filings/0001213900-26-089062.md) | [(296)](/filings/0001213900-26-043228.md) | [(328)](/filings/0001213900-26-089062.md) | [(349)](/filings/0001213900-26-055478.md) | [(373)](/filings/0001213900-26-089062.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(14.1) d](/filings/0001213900-24-098416.md) | [(8.9) d](/filings/0001213900-26-007545.md) | [(6.9)](/filings/0001213900-26-016753.md) | [(7.4) d](/filings/0001213900-26-016763.md) | [(6.5) d](/filings/0001213900-26-043228.md) | [(8.3) d](/filings/0001213900-26-043341.md) | [(16.2)](/filings/0001213900-26-055478.md) | [(4.2) d](/filings/0001213900-26-089062.md) | [(1.8) d](/filings/0001213900-26-043228.md) | [(3.8) d](/filings/0001213900-26-043341.md) | [(2.8)](/filings/0001213900-26-055478.md) | [(2.2) d](/filings/0001213900-26-089062.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001213900-24-098416.md) | [0.0 d](/filings/0001213900-26-007545.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.5](/filings/0001213900-24-027214.md) | [60.7](/filings/0001213900-24-043747.md) | [65.0](/filings/0001213900-24-068997.md) | [32.7](/filings/0001213900-24-098416.md) | [33.9](/filings/0001213900-26-016753.md) | [38.3](/filings/0001213900-26-016763.md) | [15.7](/filings/0001213900-26-043228.md) | [165](/filings/0001213900-26-055478.md) | [18.0](/filings/0001213900-26-089062.md) | [183](/filings/0001213900-26-043228.md) | [197](/filings/0001213900-26-055478.md) | [20.0](/filings/0001213900-26-089062.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,487,382 at 2026-08-11, from the cover of the [10-Q filed 2026-08-13](/filings/0001213900-26-089062.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.